Multimodality imaging using proton magnetic resonance spectroscopic imaging and (18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer Journal Article


Authors: Shukla-Dave, A.; Wassberg, C.; Pucar, D.; Schöder, H.; Goldman, D. A.; Mazaheri, Y.; Reuter, V. E.; Eastham, J.; Scardino, P. T.; Hricak, H.
Article Title: Multimodality imaging using proton magnetic resonance spectroscopic imaging and (18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer
Abstract: AIM To assess the relationship using multimodality imaging between intermediary citrate/choline metabolism as seen on proton magnetic resonance spectroscopic imaging (H-1-MRSI) and glycolysis as observed on F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) in prostate cancer (PCa) patients. METHODS The study included 22 patients with local PCa who were referred for endorectal magnetic resonance imaging/H-1-MRSI (April 2002 to July 2007) and F-18-FDG-PET/CT and then underwent prostatectomy as primary or salvage treatment. Whole-mount step-section pathology was used as the standard of reference. We assessed the relationships between PET parameters standardized uptake value (SUVmax and SUVmean)] and MRSI parameters [choline + crea-tine/citrate (CC/Cmax and CC/Cmean) and total number of suspicious voxels] using spearman's rank correlation, and the relationships of PET and H-1-MRSI index lesion parameters to surgical Gleason score. RESULTS Abnormal intermediary metabolism on H-1-MRSI was present in 21/22 patients, while abnormal glycolysis on F-18-FDG-PET/CT was detected in only 3/22 patients. Specifically, index tumor localization rates were 0.95 (95% CI: 0.77-1.00) for H-1-MRSI and 0.14 (95% CI: 0.03-0.35) for F-18-FDG-PET/CT. Spearman rank correlations indicated little relationship (rho = -0.36-0.28) between H-1-MRSI parameters and F-18-FDG-PET/CT parameters. Both the total number of suspicious voxels (rho = 0.55, P = 0.0099) and the SUVmax (rho = 0.46, P = 0.0366) correlated weakly with the Gleason score. No significant relationship was found between the CC/Cmax, CC/Cmean or SUVmean and the Gleason score (P = 0.15-0.79). CONCLUSION The concentration of intermediary metabolites detected by H-1 MRSI and glycolytic flux measured F-18-FDG PET show little correlation. Furthermore, only few tumors were FDG avid on PET, possibly because increased glycolysis represents a late and rather ominous event in the progression of PCa.
Keywords: survival; prostate cancer; radical prostatectomy; akt; pet/ct; transformation; radiation-therapy; prognostic value; cell-growth; pathological analysis; atp-citrate lyase; proton magnetic resonance spectroscopic imaging; f-18-fluorodeoxyglucose-positron emission tomography
Journal Title: World Journal of Radiology
Volume: 9
Issue: 3
ISSN: 1949-8470
Publisher: Baishideng Publishing Group Inc  
Date Published: 2017-03-28
Start Page: 134
End Page: 142
Language: English
ACCESSION: WOS:000424414600005
DOI: 10.4329/wjr.v9.i3.134
PROVIDER: wos
PMCID: PMC5368629
PUBMED: 28396727
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Peter T Scardino
    671 Scardino
  2. Heiko Schoder
    544 Schoder
  3. Hedvig Hricak
    420 Hricak
  4. James Eastham
    538 Eastham
  5. Amita Dave
    138 Dave
  6. Victor Reuter
    1228 Reuter
  7. Debra Alyssa Goldman
    158 Goldman